Volume 30, Number 12—December 2024
Research
Rio Mamore Hantavirus Endemicity, Peruvian Amazon, 2020
Table 1
Sample | IgM ELISA ratio† |
Patient age, y/sex | Patient nationality | Date | Hantavirus RT-PCR |
IgG ELISA ratio† | IFA result |
---|---|---|---|---|---|---|---|
1395 | 1.87 | 1/F | Peruvian | 2020 Jan | Negative | 0.16 | SNV-like 1.0 × 101 |
3260 | 5.00 | 5/M | Peruvian | 2020 Jan | Positive | 1.46 | SNV/ANDV-like 1.0 × 104 |
3261 | 4.00 | 3/M | Peruvian | 2020 Jan | Negative | 0.15 | Negative |
3265 | 1.36 | 32/M | Peruvian | 2020 Jan | Negative | 0.17 | Negative |
3281 | 1.22 | 1/M | Peruvian | 2020 Jan | Negative | 0.57 | Negative |
3345 | 2.96 | <1/M | Peruvian | 2020 Jan | Negative | 0.27 | Negative |
3358 | 3.73 | 45/M | Peruvian | 2020 Sep | Negative | 0.33 | Negative |
3376 | 1.25 | 27/M | Peruvian | 2020 Sep | Negative | 0.28 | SNV-like 1.0 × 101 |
3630 | 2.60 | 55/F | Peruvian | 2020 May | Negative | 0.17 | Negative |
4242 | 2.60 | 66/F | Peruvian | 2020 Sep | Negative | 0.28 | SNV/ANDV/ PUUV-like 1.0 × 101 |
4432 | 2.03 | 27/F | Peruvian | 2021 Jan | Negative | 0.33 | Negative |
4605 | 1.11 | 21/F | Foreign | 2020 Dec | Negative | 0.29 | Negative |
4893 | 1.13 | 2/M | Peruvian | 2021 Jan | Negative | 0.51 | Negative |
*ANDV, Andes virus; IFA, immunofluorescence assay; PUUV, Puumala virus; RT-PCR, reverse transcription PCR; SNV, Sin Nombre virus. †Results with a ratio greater than 1.1 are considered positive and marked in boldface.
Page created: October 25, 2024
Page updated: November 26, 2024
Page reviewed: November 26, 2024
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.